| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Department of Cell Biology and Immunology, Faculty of Medicine, Vrije Universiteit, Amsterdam, The Netherlands; and
Section Immunology, Department of Pharmacology, NV Organon, Oss, The Netherlands
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
It has been shown that Ag delivered via the nasal mucosa leads to
activation in the cervical lymph nodes in the neck region and spleen,
as can be inferred from the production of cytokines such as IL-3,
granulocyte-macrophage CSF, IL-2, and IFN-
in these organs shortly
upon Ag delivery in the nose 11 . Moreover, aerosol tolerance in rats
can be transferred to naive recipients with cells obtained from lymph
nodes draining the respiratory tract 12 . However, it remains unclear
whether the cervical lymph nodes are crucial for intranasal tolerance
induction because application of proteins in the nasal cavity may lead
to direct absorption in the blood and systemic spread 13 .
Here, we investigate in detail the involvement of the cervical lymph nodes in the induction of tolerance assayed by DTH by removal of the nodes and retransplantation of either nose-draining or peripheral lymph nodes to the sites of the original lymph nodes. Two experimental systems were used: 1) the model Ag OVA in a setting in which a read out was performed in the auricle of the ear and 2) the Ag human cartilage gp-39 (HC gp-39), a candidate autoantigen in RA 14 , in a set up in which a DTH response was monitored in the footpad. It was consistently demonstrated that the induction of immunological tolerance is fully dependent on the presence of only those lymph nodes that are originally localized in the nose-draining region.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Six- to eight-week-old female BALB/c mice were obtained from the Netherlands Cancer Institute (Amsterdam) (experiments with OVA) or from Charles River (Sulzfeld, Germany) (experiments with HC gp-39) and kept under standard laboratory conditions.
Ag trafficking after intranasal administration
Fifty micrograms of tetramethyl rhodamine isothiocyanate (TRITC)
dissolved in 10 µl 1% DMSO/PBS or 100 µg FITC in 10 µl PBS was
applied intranasally with the aid of a micropipette. After 24 h,
mice were killed and the superficial cervical, facial, internal jugular
(Fig. 1
), parathymic lymph nodes, and
spleens were removed and frozen in liquid nitrogen. Seven-micrometer
cryosections were analyzed under a fluorescence microscope
(TRITC-treated mice). Lymph node and spleen cell suspensions
(FITC-treated mice) were stained with biotinylated M5/114 (rat
anti-mouse MHC class II; 15 and streptavidin-phycoerythrin
(Jackson ImmunoResearch, West Grove, PA). Numbers of double
positive cells were determined by FACS analysis (FACScan;
Becton Dickinson, Mountain View, Ca).
|
Mice were anesthesized with 10 ml/kg body weight fentanyl/fluanison (Hypnorm)/midazolam (Dormicum, Janssen and Cilag, Saunderton, U.K.) in sterile water in a 1:1:2 (Hypnorm:Dormicum:water) ratio. A small incision was made in the skin overlying the mandibular glands. With the aid of a surgery microscope, the superficial cervical and/or facial and/or internal jugular lymph nodes were removed and the incision was closed with four to five stitches. At the end of each experiment, the mice were killed and each mouse was examined carefully for regenerated lymph nodes or nodes possibly left behind.
Transplantation of peripheral lymph nodes to the site of the paratracheal nodes
Donor popliteal, inguinal, brachial, and axillary lymph nodes were aseptically collected from naive mice and kept in sterile RPMI 1640 on ice. Recipients were anesthesized with Hypnorm/Dormicum as described above. All cervical nodes were surgically removed. At the internal jugular lymph node sites, a peripheral or a superficial cervical lymph node was placed, one on each side of the trachea. Three weeks after transplantion, intranasal OVA or HC gp-39 administration followed by a DTH-inducing protocol was performed as described below. After the experiment, all mice received rhodamin intranasally to check the presence of afferent lymphatics and in each mouse, the macroscopic appearance and microscopic composition of the transplanted lymph nodes was determined. For the latter, immunohistochemistry was performed using the mAbs MECA 367 (rat anti mouse-MAdCAM; 16 , MECA 79 (rat anti mouse L-selectin ligand 17 , 145-2C11 (hamster anti mouse-CD3; 18 , and 6B2 (rat anti mouse-B cell; 19 .
Induction of tolerance and DTH
Experiments with OVA. Mice received 100 µg OVA/10 µl PBS intranasally with the aid of a micropipette. This was repeated on 3 consecutive days. Control mice received PBS intranasally. The next day after the last intranasal treatment, mice were injected with 100 µg OVA/25 µl PBS/25 µl IFA in the tail base. Five days later, a challenge was given by injecting 10 µg OVA/20 µl PBS in the auricle of both ears, after determining the initial thickness of the ear with an engineer’s micrometer (Mititoyo, Tokyo, Japan). The increase in ear thickness was measured 24 and 48 h later.
Experiments with HC gp-39. Mice received 30 µg of HC gp-39/10 µl saline on days 15, 10, and 5 before immunization. Intranasal application was performed under light isoflurane anesthesia with the use of a Hamilton microsyringe adapted to a PT45 microconduit. Animals were immunized with 50 µg of HC gp-39/50 µl PBS/50 µl IFA at two sites on the upper part of the chest region on day 0, and challenged on day 7 in the left footpad with a 50 µl volume of 1 mg/ml HC gp-39 in 1 mg/ml alum; the right footpad was injected with 50 µl of vehiculum and served as a control. The DTH response was monitored 24 h later. A mean percentage-specific paw swelling was determined by measuring the increase in footpad thickness of the left hind footpad compared with the right hind footpad (swelling left (mm) - swelling right (mm)/swelling right (mm) x 100%), using an in-house designed micrometer.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
To study the trafficking of Ag after intranasal administration,
the fluorescent dyes FITC or TRITC were applied onto the nasal mucosa.
After 2–24 h, the dissemination of the fluorescent dyes was examined
by fluorescence microscopy of the various lymph nodes of the head-neck
region (Fig. 1
) and of the spleen. Fluorescence was found localized in
cells with dendritic morphology present in the subcapsular sinus of the
lymph nodes 2–4 h after application. Over time, these cells localized
in the paracortical, T cell-dependent areas of the lymph nodes. When
the various lymph nodes were compared, substantial numbers of
fluorescent cells were found in both the superficial cervical and
internal jugular lymph nodes. Only very few cells could be detected in
sections of other lymph nodes, draining the head-neck region such as
parathymic, mediastinal, and facial lymph nodes. In the spleen, very
few positive cells were observed in tissue sections (data not shown).
By FACS analysis of organ suspensions, these differences in
localization could be confirmed and quantified (Table I). In the superficial cervical nodes
about 10 times more cells localized than in the facial lymph nodes.
Substantial numbers of cells could also be found in the internal
jugular nodes. Strikingly, the absolute number of Ag-bearing cells was
highest in the spleen (Table I).
|
Surgical removal of nose-draining lymph nodes prevents the induction of intranasal tolerance
To study the significance of the draining lymph nodes in tolerance
induction, all or combinations of the nose-draining lymph nodes were
surgically removed. One week after removal of the lymph nodes,
intranasal tolerance induction was performed by insertion of OVA into
the nose. As shown in Fig. 2, removal of
the three types of lymph nodes completely prevented the induction of
tolerance; the development and kinetics of the DTH response in the
operated mice were completely parallel to that in sham-operated control
mice. Removing both superficial cervical and internal jugular nodes,
but leaving the facial lymph nodes in their place, prevented tolerance
induction (Fig. 3). However, by leaving
either the superficial cervical lymph nodes or the internal jugular
lymph nodes intact, and removing the other nodes, tolerance induction
could still be established (Fig. 3). In concordance with the highest
localization of Ag in these nodes, it was demonstrated that the
superficial cervical and internal jugular lymph nodes are crucial for
tolerance induction.
|
|
Removal of the superficial and internal jugular lymph nodes, but
not of the facial lymph nodes, led to impairment of tolerance
induction. This could be related to the fact that the latter showed
only limited drainage of the nasal mucosa. Therefore, we addressed the
question of whether exchange of these nose-draining lymph nodes with
any nonmucosa-associated lymph nodes would be sufficient to sustain
tolerance induction, or whether the cervical lymph nodes were unique in
that respect. Thereto, the superficial cervical, the internal jugular
nodes, and the facial lymph nodes were removed and the peripheral lymph
nodes were transplanted at the site of the internal jugular lymph
nodes. Internal control served animals that had their lymph nodes
removed and in which the internal jugular nodes were exchanged with the
superficial cervical lymph nodes. As established previously,
restoration of afferent lymphatics and blood supply was accomplished
within 1 wk 20 . Three weeks after the operation, the animals were
tested for their capacity to become tolerant after application of OVA
in the nose. Only those mice that had received the superficial cervical
lymph nodes, but not mice which had peripheral axillary nodes
transplanted, showed suppression of ear swelling in the DTH assay (Fig. 4). Immediately after the DTH
measurement, animals received TRITC in the nose to control for
efficient drainage from the nose. In all animals, fully functional
transplanted lymph nodes were found as inferred from the presence of
TRITC-positive cells (Fig. 5) and normal
localization of T and B cells as determined by immunohistochemistry
(data not shown).
|
|
). Again, after measurement of the DTH
response, mice were visually inspected for vascularization of the
transplanted lymph node and restoration of draining lymph vessels. Data
from two animals were excluded; in one animal the transplanted lymph
node was infected and in one other animal a macerated-lymph node
transplant was found, probably the result of nonvascularization.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We have demonstrated that in mice, independent of the Ag and the site of immunological challenge with such Ag, induction of tolerance via the nasal mucosa is strictly dependent on the presence of the superficial cervical or internal jugular lymph nodes. Moreover, these lymph nodes contain crucial intrinsic characteristics, because replacement of these lymph nodes with nodes from peripheral sites does not lead to tolerance induction. The efficiency of tolerance induction can be concluded from the fact that only one set of lymph nodes is sufficient. In fact, in the onset of our series of lymph node removal experiments, occasionally an animal became tolerant in spite of assumed complete removal of the lymph nodes. Upon inspection, these animals always showed incomplete removal, demonstrating that a single lymph node of either superficial cervical or internal jugular type was nevertheless sufficient to induce tolerance.
When lymph nodes are transplanted from one site to another, the disruption of blood supply and lymphatics causes major changes in the organization of the lymph node that are re-established as soon as the lymphatics and blood vessels grow in. This occurs within 7 days 20 . The majority of hematological cells, macrophages, dendritic cells, and lymphocytes will be replaced after this time, indicating that the intrinsic properties of the lymph node, as found in our tolerance experiments, must predominantly reside in stromal elements such as reticular cells, extracellular matrix components, or endothelial cells leading to specific immigration of cells from the blood.
Previously, we showed that tolerance induction via the nose involves
active T cell-mediated suppression 9, 10 . Hereto efficient Ag
presentation has to take place by APCs that enter the lymph nodes via
afferent lymphatics. No differences between localization of Ag-bearing
cells in the paracortical areas of transplanted mucosal or peripheral
lymph nodes were found (data not shown). Therefore, differences in Ag
presentation must also lie at the level of the lymph node
microenvironment, which may influence the regulation and expression of
accessory molecules on the incoming dendritic cells. In addition,
differences at the level of the immigrating T cells may also be
important. In this respect, it is interesting to note that the mucosal
superficial cervical and the internal jugular lymph nodes draining the
nasal mucosa express the mucosal addressin MAdCAM-1 on their high
endothelial venules. This adhesion molecule is absent in the facial
lymph nodes and in the transplanted peripheral lymph nodes. After
transplantation of peripheral lymph node, MAdCAM-1 expression was never
found on high endothelial venules, but it was readily expressed on the
transplanted superficial cervical nodes (Fig. 7). This is in accordance with our
previous findings in which we established that the expression of
addressins on high endothelial venules is determined perinatally and
cannot be changed after ectopic transplantation of lymph nodes in adult
life 20 . These findings imply that differences in lymphocyte
homing behavior and subsequent composition of lymphocyte population can
exist between lymph nodes that may underlie the observed divergence in
tolerance induction.
|
As seen in the localization studies, substantial numbers of Ag-bearing cells localize in the spleen after the application of Ag in the nose. It is not clear whether this leads to any substantial antigenic stimulation of T cells in the spleen. Removal of the nose-draining lymph nodes did not lead to enhanced localization of Ag-bearing cells in the spleen as determined by FACS (data not shown), or to the induction of tolerance. This argues against a specific role of the APCs from the mucosal region in tolerance induction and emphasizes the importance of the lymph node microenvironment.
In our experiments, we were not able to show a major effect of tolerance induction on the levels of specific Igs, although a shift toward Th2 isotypes was observed (data not shown and 10 . This could mean that in this model T cell tolerance is more readily induced at the level of DTH responses than T help for B cell activation. The Ag dose and efficiency of uptake may be crucial as suggested by Viney et al. 24 , who found that by in vivo increasing the number of DC, tolerance could be induced with lower amounts of Ag.
Taken together, the results show an intrinsic capacity of cervical lymph nodes to induce immunological tolerance. Factors determining this capacity could lie at the level of lymphocyte entrance and retention, but must be based on differences of stromal cells that form the basic structure of the node. It will be of great importance to study the nature of these differences to be able to use this for therapeutic applications in conditions in which tolerance induction can be extremely helpful, as in autoimmunity and allergies. As such, it is of interest that the basic rules defined in this paper, the crucial role of nose-draining lymph nodes in the induction of immunological tolerance, hold true for a model Ag (OVA) as well as for HC gp-39, a candidate autoantigen in the autoimmune disease RA. Intranasal administration of HC gp-39 has been shown not only to induce immunological nonresponsiveness to subsequent immunization with this Ag, but also to suppress HC gp-39-induced arthritis in BALB/c mice 14 . Thus, the fact that nose-draining lymph nodes are essential in the process of tolerance induction may provide further clues for effectively treating human autoimmune conditions with nasally administered autoantigens.
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Georg Kraal, Department of Cell Biology and Immunology Faculty of Medicine, Vrije Universiteit, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. E-mail address:
3 Abbreviations used in this paper: RA, rheumatoid arthritis; TRITC, tetramethyl rhodamine isothiocyanate; MAdCAM, mucosal addressin cell adhesion molecule-1; DHEA, dehydroepiandrosterone; HC gp-39, human cartilage gp-39.
Received for publication April 29, 1998. Accepted for publication November 3, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
T cells. Science 265:1869.This article has been cited by other articles:
|
|
 |
|
  J. N. Samsom, A. P. J. van der Marel, L. A. van Berkel, J. M. L. M. van Helvoort, Y. Simons-Oosterhuis, W. Jansen, M. Greuter, R. L. H. Nelissen, C. M. L. Meeuwisse, E. E. S. Nieuwenhuis, et al. Secretory Leukoprotease Inhibitor in Mucosal Lymph Node Dendritic Cells Regulates the Threshold for Mucosal Tolerance J. Immunol., November 15, 2007; 179(10): 6588 - 6595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Pabst, G. Bernhardt, and R. Forster The impact of cell-bound antigen transport on mucosal tolerance induction J. Leukoc. Biol., October 1, 2007; 82(4): 795 - 800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. J. van der Marel, J. N. Samsom, M. Greuter, L. A. van Berkel, T. O'Toole, G. Kraal, and R. E. Mebius Blockade of IDO Inhibits Nasal Tolerance Induction J. Immunol., July 15, 2007; 179(2): 894 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Alvarez, F. K. Swirski, T.-C. Yang, R. Fattouh, K. Croitoru, J. L. Bramson, M. R. Stampfli, and M. Jordana Inhalation Tolerance Is Induced Selectively in Thoracic Lymph Nodes but Executed Pervasively at Distant Mucosal and Nonmucosal Tissues J. Immunol., February 15, 2006; 176(4): 2568 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wiley, M. P. Tighe, and A. G. Harmsen Upper Respiratory Tract Resistance to Influenza Infection Is Not Prevented by the Absence of Either Nasal-Associated Lymphoid Tissue or Cervical Lymph Nodes J. Immunol., September 1, 2005; 175(5): 3186 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Ko, H.-J. Ko, W.-S. Chang, S.-H. Park, M.-N. Kweon, and C.-Y. Kang {alpha}-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor J. Immunol., September 1, 2005; 175(5): 3309 - 3317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Samsom, L. A. van Berkel, J. M. L. M. van Helvoort, W. W. J. Unger, W. Jansen, T. Thepen, R. E. Mebius, S. S. Verbeek, and G. Kraal Fc{gamma}RIIB Regulates Nasal and Oral Tolerance: A Role for Dendritic Cells J. Immunol., May 1, 2005; 174(9): 5279 - 5287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Herring, N. R. Falkowski, G.-H. Chen, R. A. McDonald, G. B. Toews, and G. B. Huffnagle Transient Neutralization of Tumor Necrosis Factor Alpha Can Produce a Chronic Fungal Infection in an Immunocompetent Host: Potential Role of Immature Dendritic Cells Infect. Immun., January 1, 2005; 73(1): 39 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cupedo and R. E. Mebius Cellular Interactions in Lymph Node Development J. Immunol., January 1, 2005; 174(1): 21 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. STAINES, C. J. DERRY, L. MARINOVA-MUTAFCHIEVA, N. ALI, D H. DAVIES, and J. J. MURPHY Constraints on the Efficacy of Mucosal Tolerance in Treatment of Human and Animal Arthritic Diseases Ann. N.Y. Acad. Sci., December 1, 2004; 1029(1): 250 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. SAMSOM, F. HAUET-BROERE, W. W. J. UNGER, L. A. VAN BERKEL, and G. KRAAL Early Events in Antigen-Specific Regulatory T Cell Induction via Nasal and Oral Mucosa Ann. N.Y. Acad. Sci., December 1, 2004; 1029(1): 385 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Plskova, L Kuffova, M Filipec, V Holan, and J V Forrester Quantitative evaluation of the corneal endothelium in the mouse after grafting Br. J. Ophthalmol., September 1, 2004; 88(9): 1209 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Camelo, A. Shanley, A. S. P. Voon, and P. G. McMenamin The Distribution of Antigen in Lymphoid Tissues following Its Injection into the Anterior Chamber of the Rat Eye J. Immunol., May 1, 2004; 172(9): 5388 - 5395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. J. Unger, F. Hauet-Broere, W. Jansen, L. A. van Berkel, G. Kraal, and J. N. Samsom Early Events in Peripheral Regulatory T Cell Induction via the Nasal Mucosa J. Immunol., November 1, 2003; 171(9): 4592 - 4603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. J. Unger, W. Jansen, D. A. W. Wolvers, A. G. S. van Halteren, G. Kraal, and J. N. Samsom Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells Int. Immunol., June 1, 2003; 15(6): 731 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Spahn, H. Herbst, P. D. Rennert, N. Lugering, C. Maaser, M. Kraft, A. Fontana, H. L. Weiner, W. Domschke, and T. Kucharzik Induction of Colitis in Mice Deficient of Peyer's Patches and Mesenteric Lymph Nodes Is Associated with Increased Disease Severity and Formation of Colonic Lymphoid Patches Am. J. Pathol., December 1, 2002; 161(6): 2273 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. de Vos, M. van Meurs, H. P. Brok, L. A. Boven, R. Q. Hintzen, P. van der Valk, R. Ravid, S. Rensing, L. Boon, B. A. 't Hart, et al. Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs J. Immunol., November 15, 2002; 169(10): 5415 - 5423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Traynor, A. C. Herring, M. E. Dorf, W. A. Kuziel, G. B. Toews, and G. B. Huffnagle Differential Roles of CC Chemokine Ligand 2/Monocyte Chemotactic Protein-1 and CCR2 in the Development of T1 Immunity J. Immunol., May 1, 2002; 168(9): 4659 - 4666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Jarnicki, T. Tsuji, and W. R. Thomas Inhibition of mucosal and systemic Th2-type immune responses by intranasal peptides containing a dominant T cell epitope of the allergen Der p 1 Int. Immunol., October 1, 2001; 13(10): 1223 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. George-Chandy, K. Eriksson, M. Lebens, I. Nordstrom, E. Schon, and J. Holmgren Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells Infect. Immun., September 1, 2001; 69(9): 5716 - 5725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D Dick, V. Sharma, and J. Liversidge Single dose intranasal administration of retinal autoantigen generates a rapid accumulation and cell activation in draining lymph node and spleen: implications for tolerance therapy Br. J. Ophthalmol., August 1, 2001; 85(8): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-R. Jiang, N. Taylor, L. Duncan, A. D Dick, and J. V Forrester Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction Br. J. Ophthalmol., June 1, 2001; 85(6): 739 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yamagami and M. R. Dana The Critical Role of Lymph Nodes in Corneal Alloimmunization and Graft Rejection Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1293 - 1298. [Abstract] [Full Text]
|
|
|
|
|
|
S.-s. J. Sung, C. E. Rose Jr., and S. M. Fu Intratracheal Priming with Ovalbumin- and Ovalbumin 323-339 Peptide-Pulsed Dendritic Cells Induces Airway Hyperresponsiveness, Lung Eosinophilia, Goblet Cell Hyperplasia, and Inflammation J. Immunol., January 15, 2001; 166(2): 1261 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Vos, A. M. M. Miltenburg, K. E. van Meijgaarden, M. van den Heuvel, D. G. Elferink, P. J. M. van Galen, R. A. van Hogezand, E. van Vliet-Daskalopoulou, T. H. M. Ottenhoff, F. C. Breedveld, et al. Cellular immune response to human cartilage glycoprotein-39 (HC gp-39)-derived peptides in rheumatoid arthritis and other inflammatory conditions Rheumatology, December 1, 2000; 39(12): 1326 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Vos, P Steenbakkers, A M M Miltenburg, E Bos, M W van den Heuvel, R A van Hogezand, R R P de Vries, F C Breedveld, and A M H Boots Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions Ann Rheum Dis, July 1, 2000; 59(7): 544 - 548. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Kitani, I. J. Fuss, K. Nakamura, O. M. Schwartz, T. Usui, and W. Strober Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (TGF)-{beta}1 Plasmid: TGF-{beta}1-mediated Suppression of T Helper Cell Type 1 Response Occurs by Interleukin (IL)-10 Induction and IL-12 Receptor {beta}2 Chain Downregulation J. Exp. Med., June 26, 2000; 192(1): 41 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|
